Hypertension in India: a systematic review and meat-analysis of prevalence, awareness and control of hypertension. J Hypertension 2014;32:1170-1177.
Trends in hypertension epidemiology in India. J Human Hypertension 2004;18:73-78.
Blood pressure matters, even during young adulthood. J Am Coll Cardiol 2011;58: 2404-2405.
Interpreting blood pressure in young adults. J Am Coll Cardiol 2015;65:336-338.
Isolated systolic hypertension in young and middle aged adults and 31 years risk for cardiovascular mortality. The Chicago Heart Association Detection Project in Industry Study. J Am Coll Cardiol 2015;65:327-335.
Blood pressure in early adulthood, hypertension in middle age and future cardiovascular disease mortality Harvard Alumni Health Study (HAHS). J Am Coll Cardiol 2011;58:2396-2403.
Blood pressure in young adulthood and mortality from cardiovascular disease. Res Letter Lancet 2000;355:1430-1431.
Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation 2010;121:1768-1777.
General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008;117:743-753.
Estimation of 10 years risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003.
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation 2014;129(suppl 2):S49-S72.
Joint British Societies’ consensusrecommendations for the prevention of cardiovascular disease (JBS3). Heart 2014;100:ii1–ii67.
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008;336:a332.
Relationship between different cardiovascular risk score and measures of subclinical atherosclerosis in an Indian population. Ind Heart J 2015;67:332-340.
Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J 2010;31:883-891.
Prevention of cardiovascular disease. Trends Cardiovasc Med 2015;25:436-442.
INTERHEART study investigators. obesity and risk of myocardial infarction in 27000 participants from 52 countries: a case control study. Lancet 2005;366: 1640-1649.
Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in south Asians. Lancet 1991;337:382-386.
Cutoff values normal anthropometric variables in Asian Indian adults. Diabetes Care 2003;26:1380-1384.
International Diabetes Federation 2005. Available at: http://www.idf.org/home.
Arterial stiffness as surrogate end point-needed clinical trials. Hypertens 2012;60: 518-522.
Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010;55:1318-1327.
Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam heart study. Circulation 2006;113:657-663.
Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients—a longitudinal study. Hypertens 2002;39:10-15.
Arterial stiffness and cardiovascular events—the Framingham heart study. Circulation 2010;121:505-511.
Predicative value of pulse wave velocity for cardiovascular events in 15520 subjects: an individual participant meta-analysis on behalf of the PWV collaborative group. J Hypertens 2010;28(Suppl A):E466.
Long-term reduction in aortic stiffness: a 5.3 years follow-up in routine clinical practice. J Hypertens 2010;28:2336-2341.
High sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001;103:1813-1818.
Comparison of c-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Eng J Med 2002;347:1557-1565.
C-reactive protein and 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation 2005;112:25-31.
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Eng J Med 2008;359:2195-2207.
The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281-1357.
Common carotid intima media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation 1997:96:1432-1437.
Risk prediction is improved by adding markers of sub clinical organ damage to SCORE. Eur Heart J 2010;31:883-891.
Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular health study collaborative research group. N Eng J Med 199;340:14-22.
Systolic and diastolic blood pressure, pulse pressure and mean arterial pressure as predictors of cardiovascular disease risk in men. Hypertension 2000;36:801-807.
Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis. Principal results of the European lacidipine study of atherosclerosis (ELSA) a randomized double blind long-term trial. Circulation 2002;106:2422-2427.
Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the atherosclerosis risk in communities (ARIC) study. J Am Coll Cardiol 2010;55:1600-1607.
Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review. Heart 2012;98:177-184.
The long-term prognostic value of the resting and post-exercise ankle brachial index. Arch Intern Med 2006;166:529-535.
Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008;300: 197-208.
Arterial hypertension, microalbuminuria and risk of ischemic heart disease. Hypertens 2000;35:898-903.
Association of cardiovascular risk factors with microalbuminuria in hypertensive Risk Assessment in Young Hypertensives individuals: the i-SEARCH global study. J Hypertens 2007;25: 2317-2324.
Reduction in albuminuria translets to reduction in cardiovascular events in hypertensive patients. Losartan intervention for endpoint reduction in hypertension study. Hypertens 2005;45:198-202.
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or Nifedipine GITS. Nephron 2002;90:169-173.